Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease

被引:8
作者
Hubbard, Demetria [1 ]
Colantonio, Lisandro D. [1 ]
Rosenson, Robert S. [2 ]
Brown, Todd M. [3 ]
Jackson, Elizabeth A. [3 ]
Huang, Lei [1 ]
Orroth, Kate K. [4 ]
Reading, Stephanie [4 ]
Woodward, Mark [5 ,6 ,7 ]
Bittner, Vera [3 ]
Gutierrez, Orlando M. [1 ]
Safford, Monika M. [8 ]
Farkouh, Michael E. [9 ,10 ]
Muntner, Paul [1 ]
机构
[1] Univ Alabama Birmingham, Dept Epidemiol, 1665 Univ Blvd,RPHB 140J, Birmingham, AL 35233 USA
[2] Icahn Sch Med Mt Sinai, Mt Sinai Heart, New York, NY 10029 USA
[3] Univ Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL USA
[4] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
[5] Imperial Coll, George Inst Global Hlth, London, England
[6] Univ New South Wales, Dept Epidemiol & Biostat, Sch Publ Hlth, George Inst Global Hlth, Kensington, NSW, Australia
[7] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
[8] Cornell Univ, Weill Cornell Med Coll, Ithaca, NY USA
[9] Univ Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada
[10] Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada
关键词
Cardiovascular disease; Chronic kidney disease; Diabetes; Myocardial infarction; Risk factors; Epidemiology;
D O I
10.1186/s12933-021-01247-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAdults who have experienced multiple cardiovascular disease (CVD) events have a very high risk for additional events. Diabetes and chronic kidney disease (CKD) are each associated with an increased risk for recurrent CVD events following a myocardial infarction (MI).MethodsWe compared the risk for recurrent CVD events among US adults with health insurance who were hospitalized for an MI between 2014 and 2017 and had (1) CVD prior to their MI but were free from diabetes or CKD (prior CVD), and those without CVD prior to their MI who had (2) diabetes only, (3) CKD only and (4) both diabetes and CKD. We followed patients from hospital discharge through December 31, 2018 for recurrent CVD events including coronary, stroke, and peripheral artery events.ResultsAmong 162,730 patients, 55.2% had prior CVD, and 28.3%, 8.3%, and 8.2% had diabetes only, CKD only, and both diabetes and CKD, respectively. The rate for recurrent CVD events per 1000 person-years was 135 among patients with prior CVD and 110, 124 and 171 among those with diabetes only, CKD only and both diabetes and CKD, respectively. Compared to patients with prior CVD, the multivariable-adjusted hazard ratio for recurrent CVD events was 0.92 (95%CI 0.90-0.95), 0.89 (95%CI: 0.85-0.93), and 1.18 (95%CI: 1.14-1.22) among those with diabetes only, CKD only, and both diabetes and CKD, respectively.ConclusionFollowing MI, adults with both diabetes and CKD had a higher risk for recurrent CVD events compared to those with prior CVD without diabetes or CKD.
引用
收藏
页数:9
相关论文
共 36 条
[1]   Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study [J].
Afkarian, Maryam ;
Katz, Ronit ;
Bansal, Nisha ;
Correa, Adolfo ;
Kestenbaum, Bryan ;
Himmelfarb, Jonathan ;
de Boer, Ian H. ;
Young, Bessie .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (08) :1384-1391
[2]   Patients with Chronic Kidney Disease/Diabetes Mellitus: The High-Risk Profile in Acute Coronary Syndrome [J].
Baber, Usman ;
Auguste, Uschi .
CURRENT CARDIOLOGY REPORTS, 2013, 15 (08)
[3]   Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries [J].
Brieger, David ;
Pocockb, Stuart J. ;
Blankenberg, Stefan ;
Chen, Ji Yan ;
Cohen, Mauricio G. ;
Granger, Christopher B. ;
Grieve, Richard ;
Nicolau, Jose C. ;
Simon, Tabassome ;
Westermann, Dirk ;
Yasuda, Satoshi ;
Gregson, John ;
Rennie, Kirsten L. ;
Hedman, Katarina ;
Sundell, Karolina Andersson ;
Goodman, Shaun G. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 311 :7-14
[4]   Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention [J].
Chamaria, Surbhi ;
Bhatheja, Samit ;
Vengrenyuk, Yuliya ;
Sweeny, Joseph ;
Choudhury, Hasan ;
Barman, Nitin ;
Mehran, Roxana ;
Sharma, Samin ;
Baber, Usman ;
Kini, Annapoorna .
AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (02) :168-176
[5]   Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial [J].
Charytan, David M. ;
Sabatine, Marc S. ;
Pedersen, Terje R. ;
Im, KyungAh ;
Park, Jeong-Gun ;
Pineda, Armando Lira ;
Wasserman, Scott M. ;
Deedwania, Prakash ;
Olsson, Anders G. ;
Sever, Peter S. ;
Keech, Anthony C. ;
Giugliano, Robert P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (23) :2961-2970
[6]   Use of Medicare Claims Data for the Identification of Myocardial Infarction: The Reasons for Geographic And Racial Differences in Stroke Study [J].
Colantonio, Lisandro D. ;
Levitan, Emily B. ;
Yun, Huifeng ;
Kilgore, Meredith L. ;
Rhodes, James D. ;
Howard, George ;
Safford, Monika M. ;
Muntner, Paul .
MEDICAL CARE, 2018, 56 (12) :1051-1059
[7]   Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status [J].
Currie, Craig J. ;
Berni, Ellen R. ;
Semi, Thomas R. ;
Jenkins-Jones, Sara ;
Sinsakul, Marvin ;
Jermutus, Lutz ;
Ambery, Philip ;
Jain, Meena .
PLOS ONE, 2019, 14 (08)
[8]   Primary and subsequent coronary risk appraisal: New results from The Framingham Study [J].
D'Agostino, RB ;
Russell, MW ;
Huse, DM ;
Ellison, RC ;
Silbershatz, H ;
Wilson, PWF ;
Hartz, SC .
AMERICAN HEART JOURNAL, 2000, 139 (02) :272-281
[9]   Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis [J].
D'Andrea, Elvira ;
Kesselheim, Aaron S. ;
Franklin, Jessica M. ;
Jung, Emily H. ;
Hey, Spencer Phillips ;
Patorno, Elisabetta .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[10]  
Fernandez -Fernandez B., 2020, SGLT2 inhibitors for non -diabetic kidney disease: Drugs to treat CKD that also improve glycaemia